Global Bioprocess Technology

Bioprocess Technology Comprehensive Study by Type (Cell Expansion, Cell Culture, Cell Line Development, Flow Cytometry, Virus Infiltration), Application (Specialty Products, Biopharmaceuticals, Environment Management, Industrial Chemicals), End User (Research Labs, Medical Institutions, Hospitals, Others) Players and Region - Global Market Outlook to 2026

Bioprocess Technology Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
A bioprocess is any process which uses complete living cells or their components for example bacteria, enzymes, chloroplast to obtain desired products. This process is commonly known to as Fermentation. Bioprocess technology deals with the design and development of equipment and procedures for the manufacturing of products. Meanwhile, bioprocesses uses living material, they deliver numerous benefits over conventional chemical methods of production including it typically need minor temperature, pressure, and pH; it uses renewable resources as raw materials and larger quantities can be produced with less energy consumption.This growth is primarily driven by High Growth in Biopharmaceutical Industry, Increase in R&D Expenditure in Developed Countries and Rise in Number of New Drug Launches.

Globally, a noticeable market trend is evident Growing Demand for Vaccines . Major Players, such as Philips Healthcare (Netherlands), Abbott Laboratories (United States), Thermo Fisher Scientific Inc. (United States), Becton, Dickinson and Company (United States), GE Healthcare (United States), Merck Millipore (Germany), Danaher Corporation (United States), Lonza Group AG (Switzerland), Sartorius Stedim Biotech S.A (France) and Charles River Laboratories (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
On May 20, 2019 - Merck has announced its participation in a collaboration with the Vaccine Formulation Institute and the European Vaccine Initiative. It will provide vaccine process development training courses within TRANSVAC2, a collaborative infrastructure project under Horizon 2020.

Regulatory Insights:
Under the authority of the Food, Drug, and Cosmetic Act of 1938, the U.S. Food and Drug Administration (FDA) evaluates and regulates the safety of biotechnology-derived products in the same way that it does for conventionally manufactured products. Scientific, safety, and regulatory issues are considered prior to approval for commercial production. Once a product receives approval, enforcement of the laws and regulations at the manufacturing level is accomplished by FDA's field personnel. The individual firm's manufacturing and quality control procedures are reviewed and evaluated to determine if they are in compliance with the Current Good Manufacturing Practice regulations.

Market Drivers
  • High Growth in Biopharmaceutical Industry
  • Increase in R&D Expenditure in Developed Countries
  • Rise in Number of New Drug Launches

Market Trend
  • Growing Demand for Vaccines
  • Increasing Prevalence of HIV and Cancer

Restraints
  • Strict Regulatory Policies

Opportunities
Potential Growth Offered by Emerging Markets and Growing Pharmaceutical Outsourcing
Challenges
Need of High Capital Investments to Set Up New Production Facilities and Difficulties in Reagent Development

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Bioprocess Technology Study Sheds Light on
— The Bioprocess Technology Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Bioprocess Technology industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Bioprocess Technology industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Cell Expansion
  • Cell Culture
  • Cell Line Development
  • Flow Cytometry
  • Virus Infiltration
By Application
  • Specialty Products
  • Biopharmaceuticals
  • Environment Management
  • Industrial Chemicals
By End User
  • Research Labs
  • Medical Institutions
  • Hospitals
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. High Growth in Biopharmaceutical Industry
      • 3.2.2. Increase in R&D Expenditure in Developed Countries
      • 3.2.3. Rise in Number of New Drug Launches
    • 3.3. Market Challenges
      • 3.3.1. Need of High Capital Investments to Set Up New Production Facilities
      • 3.3.2. Difficulties in Reagent Development
    • 3.4. Market Trends
      • 3.4.1. Growing Demand for Vaccines
      • 3.4.2. Increasing Prevalence of HIV and Cancer
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Bioprocess Technology, by Type, Application, End User and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Bioprocess Technology (Value)
      • 5.2.1. Global Bioprocess Technology by: Type (Value)
        • 5.2.1.1. Cell Expansion
        • 5.2.1.2. Cell Culture
        • 5.2.1.3. Cell Line Development
        • 5.2.1.4. Flow Cytometry
        • 5.2.1.5. Virus Infiltration
      • 5.2.2. Global Bioprocess Technology by: Application (Value)
        • 5.2.2.1. Specialty Products
        • 5.2.2.2. Biopharmaceuticals
        • 5.2.2.3. Environment Management
        • 5.2.2.4. Industrial Chemicals
      • 5.2.3. Global Bioprocess Technology by: End User (Value)
        • 5.2.3.1. Research Labs
        • 5.2.3.2. Medical Institutions
        • 5.2.3.3. Hospitals
        • 5.2.3.4. Others
      • 5.2.4. Global Bioprocess Technology Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Bioprocess Technology (Price)
      • 5.3.1. Global Bioprocess Technology by: Type (Price)
  • 6. Bioprocess Technology: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Philips Healthcare (Netherlands)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Abbott Laboratories (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Thermo Fisher Scientific Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Becton, Dickinson and Company (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. GE Healthcare (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Merck Millipore (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Danaher Corporation (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Lonza Group AG (Switzerland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sartorius Stedim Biotech S.A (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Charles River Laboratories (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Bioprocess Technology Sale, by Type, Application, End User and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Bioprocess Technology (Value)
      • 7.2.1. Global Bioprocess Technology by: Type (Value)
        • 7.2.1.1. Cell Expansion
        • 7.2.1.2. Cell Culture
        • 7.2.1.3. Cell Line Development
        • 7.2.1.4. Flow Cytometry
        • 7.2.1.5. Virus Infiltration
      • 7.2.2. Global Bioprocess Technology by: Application (Value)
        • 7.2.2.1. Specialty Products
        • 7.2.2.2. Biopharmaceuticals
        • 7.2.2.3. Environment Management
        • 7.2.2.4. Industrial Chemicals
      • 7.2.3. Global Bioprocess Technology by: End User (Value)
        • 7.2.3.1. Research Labs
        • 7.2.3.2. Medical Institutions
        • 7.2.3.3. Hospitals
        • 7.2.3.4. Others
      • 7.2.4. Global Bioprocess Technology Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Bioprocess Technology (Price)
      • 7.3.1. Global Bioprocess Technology by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Bioprocess Technology: by Type(USD Million)
  • Table 2. Bioprocess Technology Cell Expansion , by Region USD Million (2015-2020)
  • Table 3. Bioprocess Technology Cell Culture , by Region USD Million (2015-2020)
  • Table 4. Bioprocess Technology Cell Line Development , by Region USD Million (2015-2020)
  • Table 5. Bioprocess Technology Flow Cytometry , by Region USD Million (2015-2020)
  • Table 6. Bioprocess Technology Virus Infiltration , by Region USD Million (2015-2020)
  • Table 7. Bioprocess Technology: by Application(USD Million)
  • Table 8. Bioprocess Technology Specialty Products , by Region USD Million (2015-2020)
  • Table 9. Bioprocess Technology Biopharmaceuticals , by Region USD Million (2015-2020)
  • Table 10. Bioprocess Technology Environment Management , by Region USD Million (2015-2020)
  • Table 11. Bioprocess Technology Industrial Chemicals , by Region USD Million (2015-2020)
  • Table 12. Bioprocess Technology: by End User(USD Million)
  • Table 13. Bioprocess Technology Research Labs , by Region USD Million (2015-2020)
  • Table 14. Bioprocess Technology Medical Institutions , by Region USD Million (2015-2020)
  • Table 15. Bioprocess Technology Hospitals , by Region USD Million (2015-2020)
  • Table 16. Bioprocess Technology Others , by Region USD Million (2015-2020)
  • Table 17. South America Bioprocess Technology, by Country USD Million (2015-2020)
  • Table 18. South America Bioprocess Technology, by Type USD Million (2015-2020)
  • Table 19. South America Bioprocess Technology, by Application USD Million (2015-2020)
  • Table 20. South America Bioprocess Technology, by End User USD Million (2015-2020)
  • Table 21. Brazil Bioprocess Technology, by Type USD Million (2015-2020)
  • Table 22. Brazil Bioprocess Technology, by Application USD Million (2015-2020)
  • Table 23. Brazil Bioprocess Technology, by End User USD Million (2015-2020)
  • Table 24. Argentina Bioprocess Technology, by Type USD Million (2015-2020)
  • Table 25. Argentina Bioprocess Technology, by Application USD Million (2015-2020)
  • Table 26. Argentina Bioprocess Technology, by End User USD Million (2015-2020)
  • Table 27. Rest of South America Bioprocess Technology, by Type USD Million (2015-2020)
  • Table 28. Rest of South America Bioprocess Technology, by Application USD Million (2015-2020)
  • Table 29. Rest of South America Bioprocess Technology, by End User USD Million (2015-2020)
  • Table 30. Asia Pacific Bioprocess Technology, by Country USD Million (2015-2020)
  • Table 31. Asia Pacific Bioprocess Technology, by Type USD Million (2015-2020)
  • Table 32. Asia Pacific Bioprocess Technology, by Application USD Million (2015-2020)
  • Table 33. Asia Pacific Bioprocess Technology, by End User USD Million (2015-2020)
  • Table 34. China Bioprocess Technology, by Type USD Million (2015-2020)
  • Table 35. China Bioprocess Technology, by Application USD Million (2015-2020)
  • Table 36. China Bioprocess Technology, by End User USD Million (2015-2020)
  • Table 37. Japan Bioprocess Technology, by Type USD Million (2015-2020)
  • Table 38. Japan Bioprocess Technology, by Application USD Million (2015-2020)
  • Table 39. Japan Bioprocess Technology, by End User USD Million (2015-2020)
  • Table 40. India Bioprocess Technology, by Type USD Million (2015-2020)
  • Table 41. India Bioprocess Technology, by Application USD Million (2015-2020)
  • Table 42. India Bioprocess Technology, by End User USD Million (2015-2020)
  • Table 43. South Korea Bioprocess Technology, by Type USD Million (2015-2020)
  • Table 44. South Korea Bioprocess Technology, by Application USD Million (2015-2020)
  • Table 45. South Korea Bioprocess Technology, by End User USD Million (2015-2020)
  • Table 46. Taiwan Bioprocess Technology, by Type USD Million (2015-2020)
  • Table 47. Taiwan Bioprocess Technology, by Application USD Million (2015-2020)
  • Table 48. Taiwan Bioprocess Technology, by End User USD Million (2015-2020)
  • Table 49. Australia Bioprocess Technology, by Type USD Million (2015-2020)
  • Table 50. Australia Bioprocess Technology, by Application USD Million (2015-2020)
  • Table 51. Australia Bioprocess Technology, by End User USD Million (2015-2020)
  • Table 52. Rest of Asia-Pacific Bioprocess Technology, by Type USD Million (2015-2020)
  • Table 53. Rest of Asia-Pacific Bioprocess Technology, by Application USD Million (2015-2020)
  • Table 54. Rest of Asia-Pacific Bioprocess Technology, by End User USD Million (2015-2020)
  • Table 55. Europe Bioprocess Technology, by Country USD Million (2015-2020)
  • Table 56. Europe Bioprocess Technology, by Type USD Million (2015-2020)
  • Table 57. Europe Bioprocess Technology, by Application USD Million (2015-2020)
  • Table 58. Europe Bioprocess Technology, by End User USD Million (2015-2020)
  • Table 59. Germany Bioprocess Technology, by Type USD Million (2015-2020)
  • Table 60. Germany Bioprocess Technology, by Application USD Million (2015-2020)
  • Table 61. Germany Bioprocess Technology, by End User USD Million (2015-2020)
  • Table 62. France Bioprocess Technology, by Type USD Million (2015-2020)
  • Table 63. France Bioprocess Technology, by Application USD Million (2015-2020)
  • Table 64. France Bioprocess Technology, by End User USD Million (2015-2020)
  • Table 65. Italy Bioprocess Technology, by Type USD Million (2015-2020)
  • Table 66. Italy Bioprocess Technology, by Application USD Million (2015-2020)
  • Table 67. Italy Bioprocess Technology, by End User USD Million (2015-2020)
  • Table 68. United Kingdom Bioprocess Technology, by Type USD Million (2015-2020)
  • Table 69. United Kingdom Bioprocess Technology, by Application USD Million (2015-2020)
  • Table 70. United Kingdom Bioprocess Technology, by End User USD Million (2015-2020)
  • Table 71. Netherlands Bioprocess Technology, by Type USD Million (2015-2020)
  • Table 72. Netherlands Bioprocess Technology, by Application USD Million (2015-2020)
  • Table 73. Netherlands Bioprocess Technology, by End User USD Million (2015-2020)
  • Table 74. Rest of Europe Bioprocess Technology, by Type USD Million (2015-2020)
  • Table 75. Rest of Europe Bioprocess Technology, by Application USD Million (2015-2020)
  • Table 76. Rest of Europe Bioprocess Technology, by End User USD Million (2015-2020)
  • Table 77. MEA Bioprocess Technology, by Country USD Million (2015-2020)
  • Table 78. MEA Bioprocess Technology, by Type USD Million (2015-2020)
  • Table 79. MEA Bioprocess Technology, by Application USD Million (2015-2020)
  • Table 80. MEA Bioprocess Technology, by End User USD Million (2015-2020)
  • Table 81. Middle East Bioprocess Technology, by Type USD Million (2015-2020)
  • Table 82. Middle East Bioprocess Technology, by Application USD Million (2015-2020)
  • Table 83. Middle East Bioprocess Technology, by End User USD Million (2015-2020)
  • Table 84. Africa Bioprocess Technology, by Type USD Million (2015-2020)
  • Table 85. Africa Bioprocess Technology, by Application USD Million (2015-2020)
  • Table 86. Africa Bioprocess Technology, by End User USD Million (2015-2020)
  • Table 87. North America Bioprocess Technology, by Country USD Million (2015-2020)
  • Table 88. North America Bioprocess Technology, by Type USD Million (2015-2020)
  • Table 89. North America Bioprocess Technology, by Application USD Million (2015-2020)
  • Table 90. North America Bioprocess Technology, by End User USD Million (2015-2020)
  • Table 91. United States Bioprocess Technology, by Type USD Million (2015-2020)
  • Table 92. United States Bioprocess Technology, by Application USD Million (2015-2020)
  • Table 93. United States Bioprocess Technology, by End User USD Million (2015-2020)
  • Table 94. Canada Bioprocess Technology, by Type USD Million (2015-2020)
  • Table 95. Canada Bioprocess Technology, by Application USD Million (2015-2020)
  • Table 96. Canada Bioprocess Technology, by End User USD Million (2015-2020)
  • Table 97. Mexico Bioprocess Technology, by Type USD Million (2015-2020)
  • Table 98. Mexico Bioprocess Technology, by Application USD Million (2015-2020)
  • Table 99. Mexico Bioprocess Technology, by End User USD Million (2015-2020)
  • Table 100. Bioprocess Technology: by Type(USD/Units)
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Bioprocess Technology: by Type(USD Million)
  • Table 112. Bioprocess Technology Cell Expansion , by Region USD Million (2021-2026)
  • Table 113. Bioprocess Technology Cell Culture , by Region USD Million (2021-2026)
  • Table 114. Bioprocess Technology Cell Line Development , by Region USD Million (2021-2026)
  • Table 115. Bioprocess Technology Flow Cytometry , by Region USD Million (2021-2026)
  • Table 116. Bioprocess Technology Virus Infiltration , by Region USD Million (2021-2026)
  • Table 117. Bioprocess Technology: by Application(USD Million)
  • Table 118. Bioprocess Technology Specialty Products , by Region USD Million (2021-2026)
  • Table 119. Bioprocess Technology Biopharmaceuticals , by Region USD Million (2021-2026)
  • Table 120. Bioprocess Technology Environment Management , by Region USD Million (2021-2026)
  • Table 121. Bioprocess Technology Industrial Chemicals , by Region USD Million (2021-2026)
  • Table 122. Bioprocess Technology: by End User(USD Million)
  • Table 123. Bioprocess Technology Research Labs , by Region USD Million (2021-2026)
  • Table 124. Bioprocess Technology Medical Institutions , by Region USD Million (2021-2026)
  • Table 125. Bioprocess Technology Hospitals , by Region USD Million (2021-2026)
  • Table 126. Bioprocess Technology Others , by Region USD Million (2021-2026)
  • Table 127. South America Bioprocess Technology, by Country USD Million (2021-2026)
  • Table 128. South America Bioprocess Technology, by Type USD Million (2021-2026)
  • Table 129. South America Bioprocess Technology, by Application USD Million (2021-2026)
  • Table 130. South America Bioprocess Technology, by End User USD Million (2021-2026)
  • Table 131. Brazil Bioprocess Technology, by Type USD Million (2021-2026)
  • Table 132. Brazil Bioprocess Technology, by Application USD Million (2021-2026)
  • Table 133. Brazil Bioprocess Technology, by End User USD Million (2021-2026)
  • Table 134. Argentina Bioprocess Technology, by Type USD Million (2021-2026)
  • Table 135. Argentina Bioprocess Technology, by Application USD Million (2021-2026)
  • Table 136. Argentina Bioprocess Technology, by End User USD Million (2021-2026)
  • Table 137. Rest of South America Bioprocess Technology, by Type USD Million (2021-2026)
  • Table 138. Rest of South America Bioprocess Technology, by Application USD Million (2021-2026)
  • Table 139. Rest of South America Bioprocess Technology, by End User USD Million (2021-2026)
  • Table 140. Asia Pacific Bioprocess Technology, by Country USD Million (2021-2026)
  • Table 141. Asia Pacific Bioprocess Technology, by Type USD Million (2021-2026)
  • Table 142. Asia Pacific Bioprocess Technology, by Application USD Million (2021-2026)
  • Table 143. Asia Pacific Bioprocess Technology, by End User USD Million (2021-2026)
  • Table 144. China Bioprocess Technology, by Type USD Million (2021-2026)
  • Table 145. China Bioprocess Technology, by Application USD Million (2021-2026)
  • Table 146. China Bioprocess Technology, by End User USD Million (2021-2026)
  • Table 147. Japan Bioprocess Technology, by Type USD Million (2021-2026)
  • Table 148. Japan Bioprocess Technology, by Application USD Million (2021-2026)
  • Table 149. Japan Bioprocess Technology, by End User USD Million (2021-2026)
  • Table 150. India Bioprocess Technology, by Type USD Million (2021-2026)
  • Table 151. India Bioprocess Technology, by Application USD Million (2021-2026)
  • Table 152. India Bioprocess Technology, by End User USD Million (2021-2026)
  • Table 153. South Korea Bioprocess Technology, by Type USD Million (2021-2026)
  • Table 154. South Korea Bioprocess Technology, by Application USD Million (2021-2026)
  • Table 155. South Korea Bioprocess Technology, by End User USD Million (2021-2026)
  • Table 156. Taiwan Bioprocess Technology, by Type USD Million (2021-2026)
  • Table 157. Taiwan Bioprocess Technology, by Application USD Million (2021-2026)
  • Table 158. Taiwan Bioprocess Technology, by End User USD Million (2021-2026)
  • Table 159. Australia Bioprocess Technology, by Type USD Million (2021-2026)
  • Table 160. Australia Bioprocess Technology, by Application USD Million (2021-2026)
  • Table 161. Australia Bioprocess Technology, by End User USD Million (2021-2026)
  • Table 162. Rest of Asia-Pacific Bioprocess Technology, by Type USD Million (2021-2026)
  • Table 163. Rest of Asia-Pacific Bioprocess Technology, by Application USD Million (2021-2026)
  • Table 164. Rest of Asia-Pacific Bioprocess Technology, by End User USD Million (2021-2026)
  • Table 165. Europe Bioprocess Technology, by Country USD Million (2021-2026)
  • Table 166. Europe Bioprocess Technology, by Type USD Million (2021-2026)
  • Table 167. Europe Bioprocess Technology, by Application USD Million (2021-2026)
  • Table 168. Europe Bioprocess Technology, by End User USD Million (2021-2026)
  • Table 169. Germany Bioprocess Technology, by Type USD Million (2021-2026)
  • Table 170. Germany Bioprocess Technology, by Application USD Million (2021-2026)
  • Table 171. Germany Bioprocess Technology, by End User USD Million (2021-2026)
  • Table 172. France Bioprocess Technology, by Type USD Million (2021-2026)
  • Table 173. France Bioprocess Technology, by Application USD Million (2021-2026)
  • Table 174. France Bioprocess Technology, by End User USD Million (2021-2026)
  • Table 175. Italy Bioprocess Technology, by Type USD Million (2021-2026)
  • Table 176. Italy Bioprocess Technology, by Application USD Million (2021-2026)
  • Table 177. Italy Bioprocess Technology, by End User USD Million (2021-2026)
  • Table 178. United Kingdom Bioprocess Technology, by Type USD Million (2021-2026)
  • Table 179. United Kingdom Bioprocess Technology, by Application USD Million (2021-2026)
  • Table 180. United Kingdom Bioprocess Technology, by End User USD Million (2021-2026)
  • Table 181. Netherlands Bioprocess Technology, by Type USD Million (2021-2026)
  • Table 182. Netherlands Bioprocess Technology, by Application USD Million (2021-2026)
  • Table 183. Netherlands Bioprocess Technology, by End User USD Million (2021-2026)
  • Table 184. Rest of Europe Bioprocess Technology, by Type USD Million (2021-2026)
  • Table 185. Rest of Europe Bioprocess Technology, by Application USD Million (2021-2026)
  • Table 186. Rest of Europe Bioprocess Technology, by End User USD Million (2021-2026)
  • Table 187. MEA Bioprocess Technology, by Country USD Million (2021-2026)
  • Table 188. MEA Bioprocess Technology, by Type USD Million (2021-2026)
  • Table 189. MEA Bioprocess Technology, by Application USD Million (2021-2026)
  • Table 190. MEA Bioprocess Technology, by End User USD Million (2021-2026)
  • Table 191. Middle East Bioprocess Technology, by Type USD Million (2021-2026)
  • Table 192. Middle East Bioprocess Technology, by Application USD Million (2021-2026)
  • Table 193. Middle East Bioprocess Technology, by End User USD Million (2021-2026)
  • Table 194. Africa Bioprocess Technology, by Type USD Million (2021-2026)
  • Table 195. Africa Bioprocess Technology, by Application USD Million (2021-2026)
  • Table 196. Africa Bioprocess Technology, by End User USD Million (2021-2026)
  • Table 197. North America Bioprocess Technology, by Country USD Million (2021-2026)
  • Table 198. North America Bioprocess Technology, by Type USD Million (2021-2026)
  • Table 199. North America Bioprocess Technology, by Application USD Million (2021-2026)
  • Table 200. North America Bioprocess Technology, by End User USD Million (2021-2026)
  • Table 201. United States Bioprocess Technology, by Type USD Million (2021-2026)
  • Table 202. United States Bioprocess Technology, by Application USD Million (2021-2026)
  • Table 203. United States Bioprocess Technology, by End User USD Million (2021-2026)
  • Table 204. Canada Bioprocess Technology, by Type USD Million (2021-2026)
  • Table 205. Canada Bioprocess Technology, by Application USD Million (2021-2026)
  • Table 206. Canada Bioprocess Technology, by End User USD Million (2021-2026)
  • Table 207. Mexico Bioprocess Technology, by Type USD Million (2021-2026)
  • Table 208. Mexico Bioprocess Technology, by Application USD Million (2021-2026)
  • Table 209. Mexico Bioprocess Technology, by End User USD Million (2021-2026)
  • Table 210. Bioprocess Technology: by Type(USD/Units)
  • Table 211. Research Programs/Design for This Report
  • Table 212. Key Data Information from Secondary Sources
  • Table 213. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Bioprocess Technology: by Type USD Million (2015-2020)
  • Figure 5. Global Bioprocess Technology: by Application USD Million (2015-2020)
  • Figure 6. Global Bioprocess Technology: by End User USD Million (2015-2020)
  • Figure 7. South America Bioprocess Technology Share (%), by Country
  • Figure 8. Asia Pacific Bioprocess Technology Share (%), by Country
  • Figure 9. Europe Bioprocess Technology Share (%), by Country
  • Figure 10. MEA Bioprocess Technology Share (%), by Country
  • Figure 11. North America Bioprocess Technology Share (%), by Country
  • Figure 12. Global Bioprocess Technology: by Type USD/Units (2015-2020)
  • Figure 13. Global Bioprocess Technology share by Players 2020 (%)
  • Figure 14. Global Bioprocess Technology share by Players (Top 3) 2020(%)
  • Figure 15. Global Bioprocess Technology share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Philips Healthcare (Netherlands) Revenue, Net Income and Gross profit
  • Figure 18. Philips Healthcare (Netherlands) Revenue: by Geography 2020
  • Figure 19. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 20. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 21. Thermo Fisher Scientific Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Thermo Fisher Scientific Inc. (United States) Revenue: by Geography 2020
  • Figure 23. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 24. Becton, Dickinson and Company (United States) Revenue: by Geography 2020
  • Figure 25. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 26. GE Healthcare (United States) Revenue: by Geography 2020
  • Figure 27. Merck Millipore (Germany) Revenue, Net Income and Gross profit
  • Figure 28. Merck Millipore (Germany) Revenue: by Geography 2020
  • Figure 29. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 30. Danaher Corporation (United States) Revenue: by Geography 2020
  • Figure 31. Lonza Group AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 32. Lonza Group AG (Switzerland) Revenue: by Geography 2020
  • Figure 33. Sartorius Stedim Biotech S.A (France) Revenue, Net Income and Gross profit
  • Figure 34. Sartorius Stedim Biotech S.A (France) Revenue: by Geography 2020
  • Figure 35. Charles River Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 36. Charles River Laboratories (United States) Revenue: by Geography 2020
  • Figure 37. Global Bioprocess Technology: by Type USD Million (2021-2026)
  • Figure 38. Global Bioprocess Technology: by Application USD Million (2021-2026)
  • Figure 39. Global Bioprocess Technology: by End User USD Million (2021-2026)
  • Figure 40. South America Bioprocess Technology Share (%), by Country
  • Figure 41. Asia Pacific Bioprocess Technology Share (%), by Country
  • Figure 42. Europe Bioprocess Technology Share (%), by Country
  • Figure 43. MEA Bioprocess Technology Share (%), by Country
  • Figure 44. North America Bioprocess Technology Share (%), by Country
  • Figure 45. Global Bioprocess Technology: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Philips Healthcare (Netherlands)
  • Abbott Laboratories (United States)
  • Thermo Fisher Scientific Inc. (United States)
  • Becton, Dickinson and Company (United States)
  • GE Healthcare (United States)
  • Merck Millipore (Germany)
  • Danaher Corporation (United States)
  • Lonza Group AG (Switzerland)
  • Sartorius Stedim Biotech S.A (France)
  • Charles River Laboratories (United States)
Additional players considered in the study are as follows:
Corning, Inc. (United States) , Bio-Rad Laboratories (United States)
Select User Access Type

Key Highlights of Report


Sep 2021 201 Pages 54 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Bioprocess Technology Quantitative research analysis
Global Bioprocess Technology Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2016-2020; Base year: 2020; Forecast period: 2021 to 2026
Companies that are profiled in Global Bioprocess Technology Market are Philips Healthcare (Netherlands), Abbott Laboratories (United States), Thermo Fisher Scientific Inc. (United States), Becton, Dickinson and Company (United States), GE Healthcare (United States), Merck Millipore (Germany), Danaher Corporation (United States), Lonza Group AG (Switzerland), Sartorius Stedim Biotech S.A (France) and Charles River Laboratories (United States) etc.
A bioprocess is any process which uses complete living cells or their components for example bacteria, enzymes, chloroplast to obtain desired products. This process is commonly known to as Fermentation. Bioprocess technology deals with the design and development of equipment and procedures for the manufacturing of products. Meanwhile, bioprocesses uses living material, they deliver numerous benefits over conventional chemical methods of production including it typically need minor temperature, pressure, and pH; it uses renewable resources as raw materials and larger quantities can be produced with less energy consumption.

Know More About Global Bioprocess Technology Report?

Have a Query? Click Here

Other Related Reports

Waste-to-Energy Technologies Comprehensive Study by Type (Thermal, Thermo-Chemical, Mechanical-Thermal, Biochemical), Application (Heat, Fuels, Electricity), Waste Type (Municipal Solid Waste (MSW), ...
$ 3800
Antibiotic Residue Test Kits Comprehensive Study by Sales Channel (Online, Offline), End-Use (Food and Beverage Industry, Veterinary, Independent Laboratory, Others), Test Type (Beta-lactams, Macroli...
$ 3450
Branched Chain Amino Acids Comprehensive Study by Type (Proteinogenic {Leucine, Isoleucine and Valine}, Non-Proteinogenic {2-Aminoisobutyric Acid}), Application (Food & Beverages, Animal Feed, Pharma...
$ 3650
Anaerobic Incubators Comprehensive Study by Type (Workstation, Glove Box), Application (Environment Industry, Microbial Engineering, Other), Components (LED Screen Display, Temperature-Control, UV La...
$ 3650
Custom Assays Comprehensive Study by Type (Activity Assays, Competitive Assays, Elisa Assays, Sandwich Assays, Screening Assays, Conjugation Assay, Others), Application (Academic and Research Institu...
$ 3750
Oligonucleotides Comprehensive Study by Type (DNA Oligos, RNA Oligos), Application (Gene expression experiments,, Probes for microarrays, Antisense technologies, In situ hybridization, Drug carriers)...
$ 3650